Bristol Myers Squibb Co Trademarks & Logos

Mark Image Registration \| Serial	Trademark Application Date
"XEELOMMIQ" 85740961	XEELOMMIQ 2012-09-28
"BOKIQSA" 85740945	BOKIQSA 2012-09-28
"XYLUMMIQ" 85740980	XYLUMMIQ 2012-09-28
"DIMENSION" 85733523	DIMENSION 2012-09-20
"BASIS" 85733526	BASIS 2012-09-20
"ARCHITECT" 85733527	ARCHITECT 2012-09-20
"PRINCIPAL" 85733528	PRINCIPAL 2012-09-20
"ELUCIDATE" 85733522	ELUCIDATE 2012-09-20
"PEDESTAL" 4675774 85733530	PEDESTAL 2012-09-20
"MAGNITUDE" 85733525	MAGNITUDE 2012-09-20
"IMSYSTIN" 85731313	IMSYSTIN 2012-09-18
"ANREVARZ" 85731306	ANREVARZ 2012-09-18
"IMUSPARC" 85731298	IMUSPARC 2012-09-18
"LONRYM" 85731292	LONRYM 2012-09-18
"HARNESIM" 85731316	HARNESIM 2012-09-18
"AJUXIMM" 85731307	AJUXIMM 2012-09-18
"IMREVZA" 85731299	IMREVZA 2012-09-18
"IREJUV" 85731293	IREJUV 2012-09-18
"AZENMI" 85731318	AZENMI 2012-09-18
"AJUXIM" 85731309	AJUXIM 2012-09-18
"IMDEQO" 85731300	IMDEQO 2012-09-18
"LONRUPAZ" 85731294	LONRUPAZ 2012-09-18
"SKYZUR" 85731310	SKYZUR 2012-09-18
"EQUBRIMM" 85731302	EQUBRIMM 2012-09-18
"LIFCETRI" 85731296	LIFCETRI 2012-09-18
"OLIFTU" 85731312	OLIFTU 2012-09-18
"EQUBRIM" 85731303	EQUBRIM 2012-09-18
"IMVOKUS" 85731297	IMVOKUS 2012-09-18
"ALLURE - ADVANCING LEADING-EDGE LUPUS RESEARCH" 4993645 85726732	ALLURE - ADVANCING LEADING-EDGE LUPUS RESEARCH 2012-09-12
"BEPLITUDE" 85717883	BEPLITUDE 2012-08-31
"KEXPOINT" 85717885	KEXPOINT 2012-08-31
"PLUVAPAR" 85717886	PLUVAPAR 2012-08-31
"CESVONO" 85710766	CESVONO 2012-08-23
"UZANTEV" 85710759	UZANTEV 2012-08-23
"ZUNAMIK" 85710751	ZUNAMIK 2012-08-23
"ZECDELO" 85710787	ZECDELO 2012-08-23
"JEQUED" 85710760	JEQUED 2012-08-23
"ZARPSUTA" 85710753	ZARPSUTA 2012-08-23
"DIFYNIM" 85710761	DIFYNIM 2012-08-23
"UTARGZA" 85710754	UTARGZA 2012-08-23
"DIFYNIMM" 85710763	DIFYNIMM 2012-08-23
"INAZOF" 85710755	INAZOF 2012-08-23
"DEMVEP" 85710765	DEMVEP 2012-08-23
"XILTUZA" 85710757	XILTUZA 2012-08-23
"YERVOY" 4518533 85709885	YERVOY 2012-08-22
"MY NULOJIX NETWORK (BELATACEPT)" 85709858	MY NULOJIX NETWORK (BELATACEPT) 2012-08-22
"ZOTUZIF" 85688385	ZOTUZIF 2012-07-27
"LIMTROZ" 85688377	LIMTROZ 2012-07-27
"EJOXUR" 85688388	EJOXUR 2012-07-27
"XYKELO" 85688379	XYKELO 2012-07-27
"XILNEK" 85688369	XILNEK 2012-07-27
"AKAZEK" 85688391	AKAZEK 2012-07-27
"LELTUX" 85688380	LELTUX 2012-07-27
"ARXILRY" 85688372	ARXILRY 2012-07-27
"AKAZEP" 85688433	AKAZEP 2012-07-27
"ZULTEMRI" 85688382	ZULTEMRI 2012-07-27
"MLUMIQ" 85688374	MLUMIQ 2012-07-27
"XOGALPA" 85688384	XOGALPA 2012-07-27
"BEMLEK" 85688375	BEMLEK 2012-07-27
"DURUGRAF" 85687342	DURUGRAF 2012-07-26
"ZARPOINT" 85687346	ZARPOINT 2012-07-26
"DURYGRAF" 85687340	DURYGRAF 2012-07-26
"MMAZTRI" 85684226	MMAZTRI 2012-07-23
"INOQEY" 85684237	INOQEY 2012-07-23
"MVOKIS" 85683944	MVOKIS 2012-07-23
"FYDALIR" 85684241	FYDALIR 2012-07-23
"LELTUZA" 85683993	LELTUZA 2012-07-23
"XYLUMIQ" 85684246	XYLUMIQ 2012-07-23
"CAPDIMM" 85683998	CAPDIMM 2012-07-23
"INOQIMM" 85684003	INOQIMM 2012-07-23
"TUZELOT" 85679905	TUZELOT 2012-07-18
"AMEFRAME" 85679873	AMEFRAME 2012-07-18
"KEMMEV" 85679875	KEMMEV 2012-07-18
"MKIXYM" 85679877	MKIXYM 2012-07-18
"MKIXYM" 85679880	MKIXYM 2012-07-18
"ZATLUS" 85679881	ZATLUS 2012-07-18
"SALUT: STUDY OF ACTIVE LUPUS NEPHRITIS" 85678665	SALUT: STUDY OF ACTIVE LUPUS NEPHRITIS 2012-07-17
"SUPPRESS SECOND-LINE USE OF PI'S FOR PATIENTS READY TO ENGAGE IN A SUCCESSFUL STRATEGY" 85663710	SUPPRESS SECOND-LINE USE OF PI'S FOR PATIENTS READY TO ENGAGE IN A SUCCESSFUL STRATEGY 2012-06-28
"CMPASS" 85662551	CMPASS 2012-06-27
"B CARE PROGRAM SUPPORTING THE CIRCLE OF CHB CARE" 85656520	B CARE PROGRAM SUPPORTING THE CIRCLE OF CHB CARE 2012-06-20
"Symbol/Image" 5041292 85634319	Symbol/Image 2012-05-24
"UNITED IN THE FIGHT" 85630486	UNITED IN THE FIGHT 2012-05-21
"Symbol/Image" 85627920	Symbol/Image 2012-05-17
"SUBLIME: SUCCESS BEYOND 1ST LINE ANTIRETROVIRAL MEDICATIONS" 85615351	SUBLIME: SUCCESS BEYOND 1ST LINE ANTIRETROVIRAL MEDICATIONS 2012-05-03
"JOURNEYS" 4515257 85614030	JOURNEYS 2012-05-02
"IO" 85613245	IO 2012-05-01
"I-O INTERNATIONAL IMMUNO-ONCOLOGY NETWORK" 5271403 85613264	I-O INTERNATIONAL IMMUNO-ONCOLOGY NETWORK 2012-05-01
"DASCREASE" 85610302	DASCREASE 2012-04-27
"I-O INTELLIGENCE" 85610321	I-O INTELLIGENCE 2012-04-27
"IDEATE IPILIMUMAB DRUG EVALUATION IMMUNOTHERAPY IN SQUAMOUS NSCLC" 4485747 85595704	IDEATE IPILIMUMAB DRUG EVALUATION IMMUNOTHERAPY IN SQUAMOUS NSCLC 2012-04-12
"ACCESS SUPPORT" 4459704 85579496	ACCESS SUPPORT 2012-03-26
"ACCESS \| SUPPORT" 4485719 85579920	ACCESS \| SUPPORT 2012-03-26
"ZIGDUO" 85576548	ZIGDUO 2012-03-22
"SIGAFUZE" 85576529	SIGAFUZE 2012-03-22
"ZIGAFUZE" 85576537	ZIGAFUZE 2012-03-22
"SIGDUO" 85576542	SIGDUO 2012-03-22
"XINFORX" 85558537	XINFORX 2012-03-02
"XIGATU" 85558514	XIGATU 2012-03-02
"ZIGFULDA" 85558544	ZIGFULDA 2012-03-02

Mark Image

Registration | Serial

Trademark

Application Date

"ALLURE - ADVANCING LEADING-EDGE LUPUS RESEARCH"

4993645 85726732

ALLURE - ADVANCING LEADING-EDGE LUPUS RESEARCH

"MY NULOJIX NETWORK (BELATACEPT)"

85709858

MY NULOJIX NETWORK (BELATACEPT)

"SALUT: STUDY OF ACTIVE LUPUS NEPHRITIS"

85678665

SALUT: STUDY OF ACTIVE LUPUS NEPHRITIS

2012-07-17

"SUPPRESS SECOND-LINE USE OF PI'S FOR PATIENTS READY TO ENGAGE IN A SUCCESSFUL STRATEGY"

85663710

SUPPRESS SECOND-LINE USE OF PI'S FOR PATIENTS READY TO ENGAGE IN A SUCCESSFUL STRATEGY

"B CARE PROGRAM SUPPORTING THE CIRCLE OF CHB CARE"

85656520

B CARE PROGRAM SUPPORTING THE CIRCLE OF CHB CARE

"UNITED IN THE FIGHT"

"SUBLIME: SUCCESS BEYOND 1ST LINE ANTIRETROVIRAL MEDICATIONS"

85615351

SUBLIME: SUCCESS BEYOND 1ST LINE ANTIRETROVIRAL MEDICATIONS

"I-O INTERNATIONAL IMMUNO-ONCOLOGY NETWORK"

5271403 85613264

I-O INTERNATIONAL IMMUNO-ONCOLOGY NETWORK

"IDEATE IPILIMUMAB DRUG EVALUATION IMMUNOTHERAPY IN SQUAMOUS NSCLC"

4485747 85595704

IDEATE IPILIMUMAB DRUG EVALUATION IMMUNOTHERAPY IN SQUAMOUS NSCLC

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

Bristol Myers Squibb Co

USPTO Trademark & Patent Filings